Quin Wills

CEO and Founder, Ochre Bio

Quin Wills, CEO and founder of Ochre Bio, develops RNA therapies for liver disease. A medical doctor with doctorates in computational biology, mathematics and genomics, he founded Novo Nordisk’s advanced genomics department and has had roles at University College London and the Mayo Clinic. You can follow him on LinkedIn here.

Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.

Career Advice

Surviving (and thriving with) DEI in biotech

Rather than getting hung up on what to call DEI in the workplace, leaders should take three specific actions to help their employees embrace and engage with it. Companies and the patients they serve will benefit.

June 5, 2026

3 min read

Quin Wills